Status:
COMPLETED
Impact of COVID-19 on Provision and Uptake of Prevention of Mother-to-child Transmission of HIV Services in Zimbabwe
Lead Sponsor:
University of Zimbabwe
Collaborating Sponsors:
Ministry of Health and Child Welfare, Zimbabwe
Centre for Sexual Health and HIV/AIDS Research Zimbabwe (CeSHHAR Zimbabwe)
Conditions:
HIV Infections
Syphilis
Eligibility:
All Genders
Brief Summary
The COVID-19 pandemic and response are likely to lead to severe unintended consequences for the prevention of mother-to-child transmission (PMTCT) of HIV and syphilis. Zimbabwe has made huge progress ...
Detailed Description
Objectives (i) and (ii) will be met by a retrospective analysis of existing MoHCC data sources, allowing a comprehensive description and evaluation of the effects of the pandemic nationally on pMTCT s...
Eligibility Criteria
Inclusion
- Group 1:
- Inclusion criteria:
- • Anonymous aggregated data will be collated retrospectively for all pregnant women/infants receiving care at all public healthcare facilities in Zimbabwe, from March 2015 to the end of the study
- Exclusion criteria:
- None
- Group 2:
- Inclusion criteria:
- • All neonates admitted to Sally Mugabe Central Hospital, from February 2019 to the end of the study
- Exclusion criteria:
- None
- Group 3 - Pregnant/lactating women:
- Inclusion criteria:
- Accessing antenatal or postnatal services at Mabvuku and Kuwadzana clinics
- Have lived in the Mabvuku and Kuwadzana clinics catchment area during the national lockdown
- Willing and able to give written or audio informed consent for participation.
- Willing to participate in the follow-up study
- Exclusion criteria:
- None
- Group 3 - Community healthcare workers
- Inclusion criteria:
- Working and interacting directly with women seeking antenatal or postnatal care services
- Working at the health facility/ community during and prior to the lockdown
- Willing and able to give written or audio informed consent for participation.
- Exclusion criteria:
- None
Exclusion
Key Trial Info
Start Date :
March 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04782739
Start Date
March 15 2021
End Date
December 31 2022
Last Update
May 10 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Kuwadzana Polyclinic
Harare, Zimbabwe
2
Mabvuku Polyclinic
Harare, Zimbabwe